These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 5667085)

  • 21. [Effect of the combined treatment of radiation and carcinostatic agents on Yoshida-sarcoma cells].
    Saito T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1965 Nov; 25(8):908-29. PubMed ID: 5230072
    [No Abstract]   [Full Text] [Related]  

  • 22. The cancerostatic effects of some isothiocyanates on nitrogen mustard-sensitive and -resistant lines of Yoshida sarcoma.
    Miko M; Ujházy V
    Neoplasma; 1968; 15(4):357-63. PubMed ID: 5684461
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug resistance study in a mixed nitrogen mustard-sensitive-resistant tumour.
    Ujházy V
    Neoplasma; 1969; 16(4):467-8. PubMed ID: 5344233
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytembena administered in combination with cyclophosphamide in Yoshida ascitic sarcoma.
    Veselá H; Jelínek V; Pujman V; Zlatkovská Z
    Neoplasma; 1971; 18(5):459-64. PubMed ID: 5119519
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experimental study of murine Yoshida sarcoma].
    Jacotot H
    Ann Inst Pasteur (Paris); 1967 May; 112(5):601-18. PubMed ID: 4294406
    [No Abstract]   [Full Text] [Related]  

  • 26. [The cytotoxic effect of plasmin on yoshida sarcoma cells].
    Hiemeyer V; Hilgard P; Kottmann R
    Z Krebsforsch; 1969; 72(1):36-42. PubMed ID: 4183690
    [No Abstract]   [Full Text] [Related]  

  • 27. The cytotoxic effect of plasmin on Yoshida sarcoma cells.
    Hilgard P; Hiemeyer V
    Rev Fr Etud Clin Biol; 1969 Nov; 14(9):902-4. PubMed ID: 4243799
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experiments on the treatment of Yoshida tumor with neuroaminidase of Vibrio cholerae].
    Sánchez Cousteau JA; Justo Alpañes E; Ledro Molina D; Ferreiro Madueño M; Gomez Parra M; Ramírez Martínez R; Valle Bernal MJ; Astolfi Pérez de Guzmán J; Garrido Peralta M
    Rev Clin Esp; 1979 Sep; 154(5):183-6. PubMed ID: 523718
    [No Abstract]   [Full Text] [Related]  

  • 29. The absorption of 1,6-dibromo-1,6-didesoxy-d-mannitol in normal and in tumour-bearing rats.
    Csányi E
    Arzneimittelforschung; 1967 Jan; 17(1):52-5. PubMed ID: 5632528
    [No Abstract]   [Full Text] [Related]  

  • 30. Survival and frequency of pulmonary metastases in rats with implanted and removed primary Yoshida sarcoma after treatment with E-aminocaproic acid and sintrom.
    Szacki J; Lawiński M; Grzebieluch M
    Arch Immunol Ther Exp (Warsz); 1973; 21(5):763-6. PubMed ID: 4793160
    [No Abstract]   [Full Text] [Related]  

  • 31. Isolation and characterization of nitrogen mustard-sensitive cells from a nitrogen mustard-resistant subline of Yoshida sarcoma.
    Isaka H; Izumitani M; Moriwaki A; Sakurai Y
    Gan; 1966 Aug; 57(4):353-66. PubMed ID: 5969489
    [No Abstract]   [Full Text] [Related]  

  • 32. Cross-resistance studies on 1,6-dibromo-dideoxy-D-mannitol(DBM)-resistant Yoshida S.C. sarcoma.
    Csányi E; Halász M
    Br J Cancer; 1967 Jun; 21(2):353-7. PubMed ID: 6028086
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of the kinetic method for evaluation of the effectiveness of treating chronic leukemia patients with myelosan and degranol and their effect on the hemogram].
    Bala IuM; Rosnovskiĭ VS; Biriukova IV
    Probl Gematol Pereliv Krovi; 1971 May; 16(5):14-6. PubMed ID: 5292230
    [No Abstract]   [Full Text] [Related]  

  • 34. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
    Sugiura K; Merker PC
    Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
    [No Abstract]   [Full Text] [Related]  

  • 35. Growth of transplantable tumours in animals during combined treatment with cytostatics and yeast cell wall polysaccharide zymosan.
    Pfordte K; Ponsold W
    Neoplasma; 1971; 18(2):173-7. PubMed ID: 5577315
    [No Abstract]   [Full Text] [Related]  

  • 36. [Correlation of the differences of biological effects and distribution parameters of 1,6-dibromohexitols].
    Institóris L; Dzurillay E; Sebestyén JH; Jeney A; Pethes G
    Z Krebsforsch; 1971; 75(2):133-45. PubMed ID: 4256522
    [No Abstract]   [Full Text] [Related]  

  • 37. [Ineffectiveness of CH 23 in Yoshida sarcoma of the rat and mouse sarcoma 180].
    Schmähl D; Ballweg H; Berndt F; Osswald H
    Arzneimittelforschung; 1968 May; 18(5):588-9. PubMed ID: 5755887
    [No Abstract]   [Full Text] [Related]  

  • 38. Study on adjuvant therapeies in cancer chemotherapy, with special reference to the conbination of hyperthermia and hyperbaric oxygenation.
    Mori K
    Nagoya J Med Sci; 1967 Mar; 29(4):275-316. PubMed ID: 4964778
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative data on the action mechanism of 1,6-dibromo-1,6-dideoxy-D-mannitol and 1,4-dimethanesulfonyloxy-n-butane.
    Institóris L; Eckhardt S; Horváth IP; Sellei C
    Arzneimittelforschung; 1966 Jan; 16(1):45-50. PubMed ID: 5233532
    [No Abstract]   [Full Text] [Related]  

  • 40. Identical karyotypes in acquired drug-resistant sublines of Yoshida sarcoma.
    Ujhåzy V
    Neoplasma; 1974; 21(6):665-9. PubMed ID: 4444746
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.